Terns Pharmaceuticals, INC. (TERN) — DEF 14A Filings

All DEF 14A filings from Terns Pharmaceuticals, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

Terns Pharmaceuticals Files 2025 Proxy Statement — Apr 29, 2025 Risk: low
Terns Pharmaceuticals, Inc. filed its definitive proxy statement (DEF 14A) on April 29, 2025, for its annual meeting scheduled for June 11, 2025. The filing out
Terns Pharmaceuticals, Inc. Announces 2024 Annual Meeting of Stockholders — Apr 25, 2024 Risk:
Terns Pharmaceuticals, Inc. (TERN) filed a Proxy Statement (DEF 14A) with the SEC on April 25, 2024. The 2024 Annual Meeting of Stockholders for Terns Pharmaceu

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX